Episodic infusion schedule and azathioprine (Aza) intolerance correlate with the development of severe adverse reaction during infliximab (Inflix) retreatment for Crohn's disease (Cd)

被引：0
|
作者：
Attila, T
Shaker, K
Kounev, V
Levy, MB
Knox, JF
Emmons, J
Prajapati, D
Kugathasan, S
Binion, DG
机构：
来源：
GASTROENTEROLOGY | 2003年 / 124卷 / 04期
关键词：
D O I：
10.1016/S0016-5085(03)82664-1
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A526 / A526
页数：1
相关论文
共 8 条
  • [1] Infliximab Retreatment in adults and children with Crohn's disease: Risk factors for the development of delayed severe systemic reaction
    Kugathasan, S
    Levy, MB
    Saeian, K
    Vasilopoulos, S
    Kim, JP
    Prajapati, D
    Emmons, J
    Martinez, A
    Kelly, KJ
    Binion, DG
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2002, 97 (06): : 1408 - 1414
  • [2] Breastfeeding during maintenance azathioprine treatment (AZA) in patients with Crohn's disease (CD)
    Angelberger, Sieglinde
    Reinisch, Walter
    Messerschmidt, Agnes
    Miehsler, Wolfgang
    Novacek, Gottfried
    Vogelsang, Harald
    Dejaco, Clemens
    GASTROENTEROLOGY, 2008, 134 (04) : A657 - A657
  • [3] Elevated Serum IgE Prior to Acute Severe Infusion Reaction During Infliximab Maintenance Therapy in a Crohn's Disease Patient
    Kato, Shingo
    Kobayashi, Taisuke
    Kani, Kazuhito
    Takabayashi, Hidehiko
    Yamamoto, Ryuichi
    Yakabi, Koji
    INFLAMMATORY BOWEL DISEASES, 2011, 17 (12) : E156 - E157
  • [4] A prospective, randomized trial of infliximab (IFX) and azathioprine (AZA) for the induction and maintenance of remission of steroid-dependent Crohn's disease (CD)
    Mantzaris, GJ
    Ployzou, P
    Karagiannidis, A
    Christidou, A
    Koilakou, S
    Tsounis, D
    Roussos, A
    Triantafyllou, G
    Karagiannis, JA
    GASTROENTEROLOGY, 2004, 126 (04) : A54 - A54
  • [5] Development of severe psoriasis scalp with alopecia during treatment of Crohn's disease with infliximab: A paradoxical side effect
    Martinez Peinado, Carmen
    Barrera Vigo, Maria Victoria
    Valenzuela Salas, Ignacio
    Blasco Morente, Gonzalo
    Ramos Ruiz, Juan Andres
    Nogueras Morillas, Paloma
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 72 (05) : AB230 - AB230
  • [6] Swift Efficacy with Infliximab 4 Years after Initial Standard Induction Therapy Followed by Severe Delayed Infusion Reaction in Crohn's Disease
    Chiba, Mitsuro
    Tsuji, Tsuyotoshi
    Nakane, Kunio
    Obara, Yu
    Komatsu, Masafumi
    INFLAMMATORY BOWEL DISEASES, 2020, 26 (01) : E4 - E4
  • [7] Pretreatment with 6-mercaptopurine/azathioprine (6MP/AZA) prolongs clinical response time in Crohn's disease (CD) patients with fistulizing disease (FD) treated with infliximab (INF).
    Pittman, R
    Toy, LS
    Kornbluth, A
    Present, DH
    GASTROENTEROLOGY, 2000, 118 (04) : A788 - A788
  • [8] Swift Efficacy with Infliximab 4 Years after Initial Standard Induction Therapy Followed by Severe Delayed Infusion Reaction in Crohn's Disease (vol 26, pg e4, 2020)
    Chiba, Mitsuro
    Tsuji, Tsuyotoshi
    Nakane, Kunio
    Obara, Yu
    Komatsu, Masafumi
    INFLAMMATORY BOWEL DISEASES, 2020, 26 (04) : E31 - E31
1